Wide Ranks

MBIO

Mustang Bio, Inc.

0.1900

Top Statistics
Market Cap 9 M Forward PE -0.5429 Revenue Growth 0.00 %
Current Ratio 0.40 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.3180 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 3 M Total Cash Per Share 0.0740 Total Debt 983000
Total Debt To Equity Current Ratio 0.40 Book Value Per Share -0.9390
All Measures
Short Ratio 10.00 % Message Board Id finmb_326621488 Shares Short Prior Month 501966
City Worcester Uuid 15a28276-d177-3bd2-8aa8-03ffce90d2d7 Previous Close 0.2000
First Trade Date Epoch Utc 1 B Book Value -0.9390 Total Debt 983000
Volume 780283 Last Split Date 1 B Fifty Two Week Low 0.1280
Total Cash Per Share 0.0740 Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Net Income To Common -23416000 Short Percent Of Float 0.0091
Implied Shares Outstanding 47 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 627440 Average Volume10days 627440 Total Cash 3 M
Next Fiscal Year End 1 B Held Percent Insiders 0.0587 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.2000
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.2378
Open 0.2020 Free Cashflow -9369500 State MA
Dividend Yield 0.00 % Return On Assets -0.9652 Time Zone Short Name EST
Trailing Eps -1.33 Day Low 0.1860 Address1 377 Plantation Street
Shares Outstanding 46 M Price Hint 4 Target High Price 0.0000
Website https://www.mustangbio.com 52 Week Change -0.8681 Average Volume 1 M
Forward Eps -0.3500 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 25.00 % Last Split Factor 1:15 Regular Market Day High 0.2087
Is_sp_500 False Profit Margins 0.00 % Fifty Two Week High 1.66
Day High 0.2087 Shares Short 424910 Regular Market Open 0.2020
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0089 Operating Cashflow -16667000 Currency USD
Time Zone Full Name America/New_York Market Cap 9 M Is_nasdaq_100 False
Zip 01605 Quote Type EQUITY Industry Biotechnology
Long Name Mustang Bio, Inc. Regular Market Day Low 0.1860 Held Percent Institutions 0.0595
Current Price 0.1900 Address2 1st Floor Enterprise To Ebitda -0.3180
Financial Currency USD Current Ratio 0.40 Industry Disp Biotechnology
Country United States Float Shares 43 M Two Hundred Day Average 0.4597
Enterprise Value 6 M Forward PE -0.5429 Regular Market Volume 780283
Ebitda -20531000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases.

Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment.

The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus.

It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH.

The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.

Avenue  Mustang Bio, Inc. is a subsidiary of Fortress Biotech, Inc.